Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN…
News
Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023
Basel, 26 May 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new…
TScan Therapeutics Announces Pricing of $140 Million Public Offering
WALTHAM, Mass., May 26, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Tilray Brands, Inc. Announces Pricing of Registered Offering of $150 Million of Unsecured Convertible Senior Notes
Refinances a meaningful portion of our debt due in June 2024, extending maturity to 2027…
Results of a Collision Test Conducted on the Driver’s Side of a Toyota RAIZE
Toyota City, Japan, May 26, 2023 – (JCN Newswire) – On Friday, May 19, Daihatsu…
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
TOKYO, May 26, 2023 – (JCN Newswire) – Eisai and Merck & Co., Inc., Rahway,…
World Fishing Championship, the First Fishing Game on WEMIX PLAY, Launches in 170 Countries
Users become anglers to collect 500 species of fish around the world Offers a variety…
Genexine Abstract on GX-188E and GX-I7 Triple Combination Therapy in HNSCC Is Released at 2023 ASCO Annual Meeting
Triple combination using Genexine’s DNA vaccine GX-188E, its long-acting Interleukin-7 GX-I7 and Keytruda showed a…
JUNLALA Collaborates with Super Telecom Co., Ltd to Promote Computing Power Development in China’s Market
San Francisco, California–(Newsfile Corp. – May 25, 2023) – On May 19th, JUNLALA, an innovative…
‘Fujitsu Technology and Service Vision 2023’: sustainability and business converge to solve society’s challenges
TOKYO, May 26, 2023 – (JCN Newswire) – Fujitsu today published the “Fujitsu Technology and…
6th Edition of Global CX Summit, Mumbai; Physical Conference on July 6, 2023
MUMBAI, INDIA, May 26, 2023 – (ACN Newswire) – In today’s hyper-competitive business landscape, providing…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cutera, Inc. (CUTR) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Integra LifeSciences Holdings Corporation (IART) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
CORRECTION — Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
BRISBANE, Calif., May 25, 2023 (GLOBE NEWSWIRE) — In a release issued under the same…
CORRECTION — Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
BRISBANE, Calif., May 25, 2023 (GLOBE NEWSWIRE) — In a release issued under the same…
Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023…
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023…
Sekur Private Data Ltd. Releases Unaudited Financials and MDA for Q1 2023 – Sales Increase 50% Q1 2023 vs Q1 2022
Toronto, Ontario, and New York, New York–(Newsfile Corp. – May 25, 2023) – Sekur Private…